[Recommendations on the algorithms for drug choice and risk management plan in the treatment of patients with remitting multiple sclerosis with natalizumab]

Autor: L. A. Tsukurova, Sivertseva Sa, Valentina M. Alifirova, N A Malkova, I.Y. Solodun, M. N. Zakharova, I. N. Pronin, E. P. Evdoshenko, M. V. Davydovskaya, Turova Ea, A. N. Boiko, A.A. Skoromets, Khachanova Nv

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 116(10 Pt 2)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a52a4e1686ea4f33ff156dfbcf148670
https://pubmed.ncbi.nlm.nih.gov/28139616

[A role of cerebrovascular diseases in the progression of multiple sclerosis].

Autor: Sivertseva SA; Tyumen Regional Center for Multiple Sclerosis, Medical unit «Neftyanik», Tyumen, Russia.; Ural State Medical University, Yekaterinburg, Russia.; Kirov State Medical University, Kirov, Russia., Lashch NY; Pirogov Russian National Research University, Moscow, Russia., Zotova AV; Tyumen Regional Center for Multiple Sclerosis, Medical unit «Neftyanik», Tyumen, Russia., Sivertseva AM; Sechenov First Moscow State Medical University, Moscow, Russia., Titkova ER; Sechenov First Moscow State Medical University, Moscow, Russia., Boyko AN; Pirogov Russian National Research University, Moscow, Russia.; Federal Center of Brain and Neurotechnologies, Moscow, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2024; Vol. 124 (5), pp. 53-57.

[The effectiveness of tele-rehabilitation for patients with multiple sclerosis during the COVID-19 pandemic in 2020-2021 was evaluated in this study].

Autor: Sivertseva SA; Tyumen Regional Center for Multiple Sclerosis - AO MSCH «Neftyanik», Tyumen, Russia.; Ural State Medical University, Ekaterinburg, Russia., Anfilofeva KS; Tyumen Regional Center for Multiple Sclerosis - AO MSCH «Neftyanik», Tyumen, Russia., Zotova AV; Tyumen Regional Center for Multiple Sclerosis - AO MSCH «Neftyanik», Tyumen, Russia., Kazantsev VA; Tyumen Regional Center for Multiple Sclerosis - AO MSCH «Neftyanik», Tyumen, Russia.; Ural State Medical University, Ekaterinburg, Russia., Belkina AY; Ural State Medical University, Ekaterinburg, Russia.; LLC «Brain Institute Clinic», Ekaterinburg, Russia., Volkova LI; Ural State Medical University, Ekaterinburg, Russia., Guseva ME; Pirogov Russian National Research Medical University, Moscow, Russia., Boyko AN; Pirogov Russian National Research Medical University, Moscow, Russia.; Federal Center of Brain and Neurotechnologies, Moscow, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2024; Vol. 124 (3), pp. 75-81.

[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2].

Autor: Boyko AN; Pirogov Russian National Research Medical University, Moscow, Russia.; Federal Center of Brain and Neurotechnologies, Moscow, Russia., Alifirova VM; Siberian State Medical University, Tomsk, Russia., Lukashevich IG; Orden of the Red Banner of Labor City Clinical Hospital No. 1, Chelyabinsk, Russia., Goncharova ZA; Rostov State Medical University, Rostov-on-Don, Russia., Greshnova IV; Ulyanovsk Regional Clinical Hospital, Ulyanovsk, Russia., Zaslavsky LG; Leningrad Regional Clinical Hospital, St. Petersburg, Russia., Kotov SV; Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia., Malkova NA; State Novosibirsk Regional Clinical Hospital, Novosibirsk, Russia., Mishin GN; Pyatigorsk City Clinical Hospital No. 2, Pyatigorsk, Russia., Parshina EV; Semashko Nizhny Novgorod Regional Clinical Hospital, Nizhny Novgorod, Russia., Poverennova IY; Seredavin Samara Regional Clinical Hospital, Samara, Russia., Prakhova LN; N. Bechtereva Institute of the Human Brain, St. Petersburg, Russia., Sivertseva SA; Medical and Sanitary unit «Neftyanik», Tyumen, Russia., Smagina IV; Regional Clinical Hospital, Barnaul, Russia., Totolyan NA; Academician I.P. Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia., Trinitatsky YV; Rostov Regional Clinical Hospital, Rostov-on-Don, Russia., Trushnikova TN; Wagner Perm State Medical University, Perm, Russia., Khabirov FA; Republican Clinical Nerological Center, Kazan, Russia., Shchur SG; Municipal Filatov Clinical Hospital No. 15, Moscow, Russia., Artemyeva AV; AO BIOCAD, St. Petersburg, Russia., Bolsun DD; AO BIOCAD, St. Petersburg, Russia., Zinkina-Orikhan AV; AO BIOCAD, St. Petersburg, Russia., Linkova YN; AO BIOCAD, St. Petersburg, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2023; Vol. 123 (4), pp. 37-47.

[Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].

Autor: Boyko AN; Pirogov Russian National Research Medical University, Moscow, Russia.; Federal Center of Brain and Neurotechnologies of the Federal Medical Biological Agency, Moscow, Russia., Alifirova VM; Siberian State Medical University, Tomsk, Russia., Lukashevich IG; City Clinical Hospital No. 1, Chelyabinsk, Russia., Goncharova ZA; Rostov State Medical University, Rostov-on-Don, Russia., Greshnova IV; Ulyanovsk Regional Clinical Hospital, Ulyanovsk, Russia., Zaslavsky LG; Leningrad Regional Clinical Hospital, St. Petersburg, Russia., Kotov SV; Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia., Malkova NA; State Novosibirsk Regional Clinical Hospital, Novosibirsk, Russia., Mishin GN; Pyatigorsk City Clinical Hospital No. 2, Pyatigorsk, Russia., Parshina EV; Semashko Nizhny Novgorod Regional Clinical Hospital, Nizhny Novgorod, Russia., Poverennova IY; Seredavin Samara Regional Clinical Hospital, Samara, Russia., Prakhova LN; N. Bechtereva Institute of the Human Brain, St. Petersburg, Russia., Sivertseva SA; Medical and Sanitary unit «Neftyanik», Tyumen, Russia., Smagina IV; Regional Clinical Hospital, Barnaul, Russia., Totolyan NA; Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia., Trinitatsky YV; Rostov Regional Clinical Hospital, Rostov-on-Don, Russia., Trushnikova TN; Wagner Perm State Medical University, Perm, Russia., Khabirov FA; Republican Clinical Nerological Center, Kazan, Russia., Chefranova JY; Belgorod Regional Clinical Hospital of St. Joasaph, Belgogrod, Russia., Shchur SG; Municipal Filatov Clinical Hospital No. 15, Moscow, Russia., Dudin VA; Center for Cardiology and Neurology», Kirov, Russia., Pokhabov DV; Federal Siberian Scientific and Clinical Center, Krasnoyarsk, Russia., Bolsun DD; JSC BIOCAD, St. Petersburg, Russia., Eremeeva AV; JSC BIOCAD, St. Petersburg, Russia., Linkova YN; JSC BIOCAD, St. Petersburg, Russia., Zinkina-Orikhan AV; JSC BIOCAD, St. Petersburg, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2023; Vol. 123 (7. Vyp. 2), pp. 43-52.